imcannabis.com (IMCC) - Forward P/S Multiple

Public company logo of IM Cannabis Corp (IMCC)

The seamless delegation of global supplies to logistics providers is stabilizing dynamics for IM Cannabis Corp. (IMCC), and consequently, the forward price-to-sales ratio reflects the current market valuation, with the value fixed at 0.00. Growth is supported by IM Cannabis Corp. (IMCC)'s leadership in medical cannabis exports to Europe and Israel, as well as the recruitment of leading agronomists and scientists to develop innovative products.

IM Cannabis Corp - IMCC Forward P/S Multiple (period 07/04/2022 - 11/14/2026)

imcannabis.com - analytical breakdowns and key metrics (IMCC)

- stock price and consensus target price:
Stock Quotes IM Cannabis|IMCC - Fair Value Consensus
- market capitalization indicators:
Market Capitalization IM Cannabis Corp.|IMCC - Real Price to Acquire Entire Company
- issuer book value statistics:
Book Value per Share IM Cannabis|IMCC - Book Capitalization|Market Value to Book Value Ratio imcannabis.com|IMCC - Total Business Assets
- debt level and financial liquidity data:
Debt to Equity IM Cannabis Corp.|IMCC - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital IM Cannabis|IMCC - Company Aggregate Debts|Debts to Book Capitalization IM Cannabis Corp.|IMCC - Company Long-Term Debt|Company Short-Term Debts IM Cannabis|Quick Liquidity imcannabis.com
- financial results and valuation multiples details:
IMCC - Net Financial Result|Future Profit IM Cannabis Corp.|IMCC - Company Value to Net Income|Forward P/E Multiple IM Cannabis|IMCC - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IM Cannabis Corp.|IMCC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months IM Cannabis|IMCC - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months imcannabis.com|IMCC - Earnings per share trend in current year|Expected earnings per share growth for next year IM Cannabis Corp.
- total revenue and sales volume data:
IMCC - Company Gross Revenue|Projected Sales Volume IM Cannabis|IMCC - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio IM Cannabis Corp.
Fundamental company analysis:IMC IMCC
Original product of imcannabis.com

To protect capital from volatility, it is crucial for investors to distinguish speculative noise from a genuine asset revaluation. The expansion of IM Cannabis Corp. (IMCC) into the growing markets of Germany and Israel confirms a fundamental shift reflected in the future P/S multiple, comparing current market capitalization with projected revenue to determine the company's fair value and filter out short-term market fluctuations within the portfolio.

Who IM Cannabis Corp. competes with

Indivior - Forward Price-to-Revenue Multiple|Forward Price to Sales COLL|Cronos - Forward P/S Multiple|Canopy Growth Corp. (CGC) - Forward Price-to-Revenue Multiple|HITI: Forward P/S Multiple|Aurora Cannabis Inc. (ACB) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Achieve Life Sciences, Inc.|Market Cap to Projected Revenue SKYE (Skye Bioscience Inc.)|Price-to-Projected Revenue Ratio Anebulo (ANEB)|intercure.co - Market Cap to Projected Revenue|Forward P/S Multiple NTRB (Nutriband)|Forward P/S Multiple Nasus Pharma Ltd. NSRX|IGC Pharma Inc - Forward P/S Multiple|MIRA: Price-to-Projected Revenue Ratio|FLGC: Forward P/S Multiple|ADIL - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Artelo Biosciences Inc.|Ensysce (ENSC) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple TTNP (Titan Pharmaceuticals)|GNLN (Greenlane Holdings, Inc.) - Forward Price to Sales|Forward P/S Multiple INM (InMed Pharma)|AKAN - Forward Price-to-Revenue Multiple|ENVB - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Bright Green|Hempacco Co., Inc. (HPCO) - Price-to-Projected Revenue Ratio